Floatz logo

32 assets in Prostate Neuroendocrine Neoplasm

Therapeutic assets addressing Prostate Neuroendocrine Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Carboplatin
Prostate Neuroendocrine Neoplasm
Phanes TherapeuticsP2B (61)
Oxodotreotide
Prostate Neuroendocrine Neoplasm
Novartis PharmaceuticalsP2B (60)
Tarlatamab
Prostate Neuroendocrine Neoplasm
Inkeun ParkP2B (60)
Cabazitaxel
Prostate Neuroendocrine Neoplasm
Andrew J. Armstrong, MDP2CCC (53)
Cediranib
Prostate Neuroendocrine Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Cetrelimab
Prostate Neuroendocrine Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Ipilimumab
Prostate Neuroendocrine Neoplasm
Andrew J. Armstrong, MDP2CCC (53)
Memantine Hydrochloride
Prostate Neuroendocrine Neoplasm
Bin XuP2CCC (53)
Niraparib
Prostate Neuroendocrine Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Nivolumab
Prostate Neuroendocrine Neoplasm
Andrew J. Armstrong, MDP2CCC (53)
Olaparib
Prostate Neuroendocrine Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Regorafenib
Prostate Neuroendocrine Neoplasm
Translational Research in OncologyP2CCC (53)
Sacituzumab Tirumotecan
Prostate Neuroendocrine Neoplasm
Virginia Commonwealth UniversityP2CCC (53)
Tislelizumab
Prostate Neuroendocrine Neoplasm
Translational Research in OncologyP2CCC (53)
zg006
Prostate Neuroendocrine Neoplasm
Suzhou Zelgen Biopharmaceuticals Co.,LtdP2CCC (53)
Etoposide
Prostate Neuroendocrine Neoplasm
Phanes TherapeuticsP1/2CCC (52)
Atezolizumab
Prostate Neuroendocrine Neoplasm
Phanes TherapeuticsP1/2CC (47)
Immunoglobulin H-Gamma1_L-Kappa, Anti-[Homo Sapiens Cd47 (Cd47 Molecule, Integrin Associated Protein, Iap, Mer6, Oa3) And Anti-[Homo Sapiens Dll3 (Delta-Like Ligand 3, Delta Like Canonical Notch Ligand 3)], Bispecific;
Prostate Neuroendocrine Neoplasm
Phanes TherapeuticsP1/2CC (47)
111in-etn029
Prostate Neuroendocrine Neoplasm
Novartis PharmaceuticalsP1CC (43)
[111in]-fpi-2058
Prostate Neuroendocrine Neoplasm
3B Pharmaceuticals GmbHP1CC (43)
177lu-dtpa-sc16.56
Prostate Neuroendocrine Neoplasm
Memorial Sloan Kettering Cancer CenterP1CC (43)
225ac-etn029
Prostate Neuroendocrine Neoplasm
Novartis PharmaceuticalsP1CC (43)
[225]-fpi-2059
Prostate Neuroendocrine Neoplasm
3B Pharmaceuticals GmbHP1CC (43)
AXUMIN
Prostate Neuroendocrine Neoplasm
Brigham and Women's HospitalP1CC (43)
Bl-M14D1
Prostate Neuroendocrine Neoplasm
SystImmune Inc.P1CC (43)
Cis-Diamminedichloroplatinum Ii
Prostate Neuroendocrine Neoplasm
Jonsson Comprehensive Cancer CenterP1CC (43)
Docetaxel
Prostate Neuroendocrine Neoplasm
Jonsson Comprehensive Cancer CenterP1CC (43)
Dota-Pabza-Dig-Dphe-Gln-Trp-Ala-Val-Gly-His-Nhch(Ch2Ch(Ch3)2)2
Prostate Neuroendocrine Neoplasm
Novartis PharmaceuticalsP1CC (43)
Metoclopramide
Prostate Neuroendocrine Neoplasm
Novartis PharmaceuticalsP1CC (43)
ML261
Prostate Neuroendocrine Neoplasm
Moonlight Bio, IncP1CC (43)
Pembrolizumab
Prostate Neuroendocrine Neoplasm
Jonsson Comprehensive Cancer CenterP1CC (43)
esk981
Prostate Neuroendocrine Neoplasm
University of Michigan Rogel Cancer CenterP2NR ()